SOD1 and amyotrophic lateral sclerosis: Their study reported a 38.8% reduction in cytosolic SOD (mainly SOD1) activity in post-mortem brain tissues of ALS patients with SOD1 mutations (mutation in exon1; specific variant not provided) compared to controls.